- COMPOUNDS AS MODULATORS OF ROR GAMMA
-
The present invention encompasses compounds of the formula (I)(I) wherein the variables are defined herein which are suitable for the modulation of RORγ and the treatment of diseases related to the modulation of RORγ. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.
- -
-
Page/Page column 131
(2019/03/28)
-
- COMPOUNDS AS MODULATORS OF ROR GAMMA
-
The present invention encompasses compounds of the formula (I) wherein the variables are defined herein which are suitable for the modulation of RORγ and the treatment of diseases related to the modulation of RORγ. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.
- -
-
Page/Page column 141-142
(2015/11/09)
-
- Triazolopyrimidine cannabinoid receptor 1 antagonists
-
The present application describes compounds according to both Formulas I and II, pharmaceutical compositions comprising at least one compound according to either Formula I or II and optionally one or more additional therapeutic agents, and methods of treatment using the compounds according to Formulas I and II both alone and in combination with one or more additional therapeutic agents. The compounds have the following general formulas: including all prodrugs, solvates, pharmaceutically acceptable salts and stereoisomers, wherein R1, R2, R3, R4 and R5 are described herein.
- -
-
Page/Page column 41
(2010/11/25)
-
